The pathological spectrum of solid CNS metastases in the pediatric population: Clinical article

Andrea L. Wiens, Eyas M. Hattab

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Object. Collectively, metastatic tumors are the most common malignancy encountered in the adult central nervous system (CNS), arising most often from lung, breast, skin, and gastrointestinal tract carcinomas. Limited information is available in the literature regarding solid nonhematopoietic CNS metastases in children. The authors carried out a retrospective study of pediatric metastatic neoplasms to the CNS treated in a 30-year period to characterize their frequency, common histological subtypes, and sites of origin. Methods. The archival pathology files were searched (1981-2011) for metastatic tumors to the CNS in patients 21 years of age and younger. Pathology material was reviewed, tumors were classified by site of origin and histological subtype, and survival was evaluated. Results. The authors identified 26 patients with solid nonhematopoietic CNS metastases out of 1135 pediatric CNS tumors diagnosed from 1981 to 2011. Patients ranged in age from 1.5 to 20.3 years and were equally divided between sexes. Most CNS metastases were supratentorial (85%) and solitary (65%). The mean interval from primary malignant diagnosis to CNS metastasis was 27 months. Sites of origin included kidney/adrenal, bone/soft tissue, gonads, head and neck, lung, and liver. Mean survival after CNS involvement was 36.6 months. Overall 1-year and 5-year survival rates were 52% and 16%, respectively. Conclusions. In neuropathology practice, nonhematopoietic pediatric CNS metastases are far less common than are nonhematopoietic adult CNS metastases, accounting for approximately 2% of all pediatric CNS tumors. The most common tumors to exhibit CNS metastasis are of kidney/adrenal origin, followed by those from bone/soft tissue. As expected, prognosis is dismal, despite aggressive therapy.

Original languageEnglish
Pages (from-to)129-135
Number of pages7
JournalJournal of Neurosurgery: Pediatrics
Volume14
Issue number2
DOIs
StatePublished - 2014

Fingerprint

Central Nervous System
Pediatrics
Neoplasm Metastasis
Central Nervous System Neoplasms
Population
Neoplasms
Pathology
Kidney
Bone and Bones
Lung
Survival
Gonads
Gastrointestinal Tract
Breast
Neck
Survival Rate
Retrospective Studies
Head
Carcinoma
Skin

Keywords

  • CNS metastases
  • Ewing sarcoma
  • Mixed germ cell tumor
  • Nephroblastoma tumor
  • Neuroblastoma
  • Oncology
  • Pediatric brain tumors
  • PNET
  • Rhabdomyosarcoma
  • Wilms tumor

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery
  • Pediatrics, Perinatology, and Child Health

Cite this

The pathological spectrum of solid CNS metastases in the pediatric population : Clinical article. / Wiens, Andrea L.; Hattab, Eyas M.

In: Journal of Neurosurgery: Pediatrics, Vol. 14, No. 2, 2014, p. 129-135.

Research output: Contribution to journalArticle

@article{3d566417a7d64ca4a1d7b254d2af422a,
title = "The pathological spectrum of solid CNS metastases in the pediatric population: Clinical article",
abstract = "Object. Collectively, metastatic tumors are the most common malignancy encountered in the adult central nervous system (CNS), arising most often from lung, breast, skin, and gastrointestinal tract carcinomas. Limited information is available in the literature regarding solid nonhematopoietic CNS metastases in children. The authors carried out a retrospective study of pediatric metastatic neoplasms to the CNS treated in a 30-year period to characterize their frequency, common histological subtypes, and sites of origin. Methods. The archival pathology files were searched (1981-2011) for metastatic tumors to the CNS in patients 21 years of age and younger. Pathology material was reviewed, tumors were classified by site of origin and histological subtype, and survival was evaluated. Results. The authors identified 26 patients with solid nonhematopoietic CNS metastases out of 1135 pediatric CNS tumors diagnosed from 1981 to 2011. Patients ranged in age from 1.5 to 20.3 years and were equally divided between sexes. Most CNS metastases were supratentorial (85{\%}) and solitary (65{\%}). The mean interval from primary malignant diagnosis to CNS metastasis was 27 months. Sites of origin included kidney/adrenal, bone/soft tissue, gonads, head and neck, lung, and liver. Mean survival after CNS involvement was 36.6 months. Overall 1-year and 5-year survival rates were 52{\%} and 16{\%}, respectively. Conclusions. In neuropathology practice, nonhematopoietic pediatric CNS metastases are far less common than are nonhematopoietic adult CNS metastases, accounting for approximately 2{\%} of all pediatric CNS tumors. The most common tumors to exhibit CNS metastasis are of kidney/adrenal origin, followed by those from bone/soft tissue. As expected, prognosis is dismal, despite aggressive therapy.",
keywords = "CNS metastases, Ewing sarcoma, Mixed germ cell tumor, Nephroblastoma tumor, Neuroblastoma, Oncology, Pediatric brain tumors, PNET, Rhabdomyosarcoma, Wilms tumor",
author = "Wiens, {Andrea L.} and Hattab, {Eyas M.}",
year = "2014",
doi = "10.3171/2014.5.PEDS13526",
language = "English",
volume = "14",
pages = "129--135",
journal = "Journal of Neurosurgery: Pediatrics",
issn = "1933-0707",
publisher = "American Association of Neurological Surgeons",
number = "2",

}

TY - JOUR

T1 - The pathological spectrum of solid CNS metastases in the pediatric population

T2 - Clinical article

AU - Wiens, Andrea L.

AU - Hattab, Eyas M.

PY - 2014

Y1 - 2014

N2 - Object. Collectively, metastatic tumors are the most common malignancy encountered in the adult central nervous system (CNS), arising most often from lung, breast, skin, and gastrointestinal tract carcinomas. Limited information is available in the literature regarding solid nonhematopoietic CNS metastases in children. The authors carried out a retrospective study of pediatric metastatic neoplasms to the CNS treated in a 30-year period to characterize their frequency, common histological subtypes, and sites of origin. Methods. The archival pathology files were searched (1981-2011) for metastatic tumors to the CNS in patients 21 years of age and younger. Pathology material was reviewed, tumors were classified by site of origin and histological subtype, and survival was evaluated. Results. The authors identified 26 patients with solid nonhematopoietic CNS metastases out of 1135 pediatric CNS tumors diagnosed from 1981 to 2011. Patients ranged in age from 1.5 to 20.3 years and were equally divided between sexes. Most CNS metastases were supratentorial (85%) and solitary (65%). The mean interval from primary malignant diagnosis to CNS metastasis was 27 months. Sites of origin included kidney/adrenal, bone/soft tissue, gonads, head and neck, lung, and liver. Mean survival after CNS involvement was 36.6 months. Overall 1-year and 5-year survival rates were 52% and 16%, respectively. Conclusions. In neuropathology practice, nonhematopoietic pediatric CNS metastases are far less common than are nonhematopoietic adult CNS metastases, accounting for approximately 2% of all pediatric CNS tumors. The most common tumors to exhibit CNS metastasis are of kidney/adrenal origin, followed by those from bone/soft tissue. As expected, prognosis is dismal, despite aggressive therapy.

AB - Object. Collectively, metastatic tumors are the most common malignancy encountered in the adult central nervous system (CNS), arising most often from lung, breast, skin, and gastrointestinal tract carcinomas. Limited information is available in the literature regarding solid nonhematopoietic CNS metastases in children. The authors carried out a retrospective study of pediatric metastatic neoplasms to the CNS treated in a 30-year period to characterize their frequency, common histological subtypes, and sites of origin. Methods. The archival pathology files were searched (1981-2011) for metastatic tumors to the CNS in patients 21 years of age and younger. Pathology material was reviewed, tumors were classified by site of origin and histological subtype, and survival was evaluated. Results. The authors identified 26 patients with solid nonhematopoietic CNS metastases out of 1135 pediatric CNS tumors diagnosed from 1981 to 2011. Patients ranged in age from 1.5 to 20.3 years and were equally divided between sexes. Most CNS metastases were supratentorial (85%) and solitary (65%). The mean interval from primary malignant diagnosis to CNS metastasis was 27 months. Sites of origin included kidney/adrenal, bone/soft tissue, gonads, head and neck, lung, and liver. Mean survival after CNS involvement was 36.6 months. Overall 1-year and 5-year survival rates were 52% and 16%, respectively. Conclusions. In neuropathology practice, nonhematopoietic pediatric CNS metastases are far less common than are nonhematopoietic adult CNS metastases, accounting for approximately 2% of all pediatric CNS tumors. The most common tumors to exhibit CNS metastasis are of kidney/adrenal origin, followed by those from bone/soft tissue. As expected, prognosis is dismal, despite aggressive therapy.

KW - CNS metastases

KW - Ewing sarcoma

KW - Mixed germ cell tumor

KW - Nephroblastoma tumor

KW - Neuroblastoma

KW - Oncology

KW - Pediatric brain tumors

KW - PNET

KW - Rhabdomyosarcoma

KW - Wilms tumor

UR - http://www.scopus.com/inward/record.url?scp=84905452047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905452047&partnerID=8YFLogxK

U2 - 10.3171/2014.5.PEDS13526

DO - 10.3171/2014.5.PEDS13526

M3 - Article

C2 - 24926970

AN - SCOPUS:84905452047

VL - 14

SP - 129

EP - 135

JO - Journal of Neurosurgery: Pediatrics

JF - Journal of Neurosurgery: Pediatrics

SN - 1933-0707

IS - 2

ER -